What you pop for diabetes could turn fatal

[Guest guest]

What you pop for diabetes could turn fatal

 

Harmanpreet Kaur / CNN-IBN

 

TimePublished on Tuesday , July 31, 2007 at 12:57 in Health section

 

New Delhi: It's disturbing news for the 40 million Indians living with

diabetes type II. Two drugs commonly used in treatment can double the

risk of heart failure, finds a US study.

 

The drugs - Rosiglitazone and Pioglitazone of the class of drugs

called Thiazolinediones are frequently used by almost five to 7.5

million diabetics in India.

 

The study finds that over a 26-month period, for every 50 diabetes

type II patients taking the drug there would be one extra heart

failure.

 

" We knew that they cause fluid retention four years ago but this study

for the first time is done on a large scale and confirms that they do

cause heart failure, " says Dr Anoop Misra.

 

Other alternatives to these drugs are widely available today. So,

consult your physician for advice, if you are being prescribed the

following drugs.

 

Rosiglitazone

 

* Winidia (GSK)

 

* Enselin (Torrent)

 

* Rosinorm (Micro)

 

* Rosizon(Emcure)

 

Pioglitazone

 

# Opam (Wockhardt Ltd)

 

# Diavista (Dr Reddy's)

 

# Dibizone (Novartis)

 

# Iozone (Nicolas Piramal)

 

" This study shows that it is not just possible in elderly and those

susceptible to heart disease but also younger people, " says Dr Misra.

 

The US FDA issued a warning against these drugs in May. Although there

has been no official warning in India, doctors are increasingly opting

for other alternatives.

 

 

http://www.ibnlive.com/news/what-you-pop-for-diabetes-could-turn-fatal/45924-17.\

html

[Guest guest]

Don't miss Avandia -- going to be a huge scandal like HRT and Thalidomide.Puneet <puneet.nospam wrote: What you pop for diabetes could turn fatalHarmanpreet Kaur / CNN-IBNTimePublished on Tuesday , July 31, 2007 at 12:57 in Health sectionNew Delhi: It's disturbing news for the 40 million Indians living withdiabetes type II. Two drugs commonly used in treatment can double therisk of heart failure, finds a US study.The drugs - Rosiglitazone and Pioglitazone of the class of

drugscalled Thiazolinediones are frequently used by almost five to 7.5million diabetics in India.The study finds that over a 26-month period, for every 50 diabetestype II patients taking the drug there would be one extra heartfailure."We knew that they cause fluid retention four years ago but this studyfor the first time is done on a large scale and confirms that they docause heart failure," says Dr Anoop Misra.Other alternatives to these drugs are widely available today. So,consult your physician for advice, if you are being prescribed thefollowing drugs.Rosiglitazone* Winidia (GSK)* Enselin (Torrent)* Rosinorm (Micro)* Rosizon(Emcure)Pioglitazone# Opam (Wockhardt Ltd)# Diavista (Dr Reddy's)# Dibizone (Novartis)# Iozone (Nicolas Piramal)"This study shows that it is not just possible in elderly and thosesusceptible to heart

disease but also younger people," says Dr Misra.The US FDA issued a warning against these drugs in May. Although therehas been no official warning in India, doctors are increasingly optingfor other alternatives.http://www.ibnlive.com/news/what-you-pop-for-diabetes-could-turn-fatal/45924-17.html

Did you know? You can CHAT without downloading messenger. Click here